Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Despite enrollment growth and strategic initiatives, the company faces significant challenges: a 25% YoY revenue decrease, reduced gross margins, and ongoing cash flow issues. The positive aspects, such as NCQA certification and potential revenue growth, are overshadowed by reliance on new contracts and financial strain. The lack of significant Q&A insights further supports a negative outlook. Overall, the negatives outweigh the positives, suggesting a potential stock price decline of 2% to 8%.
Revenue $2 million, reflecting a 25% decrease year-over-year due to the loss of a customer whose members disenrolled at the end of 2024, partially offset by new customers and expansions of existing customers.
Total Enrolled Members 3,165 members at the end of Q1, nearly doubling year-over-year, indicating strong growth and validation of the effectiveness of the enhanced multi-solution approach.
Revenue per Health Plan Enrolled Member per Month Approximately $254, a decrease from $500 in Q4 2024 and $504 in Q1 2024, primarily due to the lost customer and a shift in the mix of members with a larger percentage in the Engage program.
New Members Enrolled 2,039 new members added during the quarter, the highest since Q3 2021, compared to 1,641 in Q4 2024 and 925 in Q1 2024.
Average Monthly Disenrollment Rate 10%, down from 19% in Q4 2024 and 22% in Q1 2024, due to disenrollment of members from customers who discontinued service.
Gross Margin 37%, a decrease from 61% in Q4 2024 and 63.6% in Q1 2024, primarily driven by the decrease in revenue from the lost customer and the mix shift of members in the Engage program.
Cash Flow from Operations Negative $2.7 million, an improvement from negative $3.3 million in the same period last year and negative $4.3 million in Q4 2024.
Cash Reserves $4.1 million at quarter end, down from $5.7 million at the end of 2024.
Engage Program: The Engage program has significantly expanded Ontrak's market reach by enabling the company to serve members who may not require the WholeHealth+ program but still benefit from structured behavioral health support.
WholeHealth+ Implementation: Ontrak has implemented WholeHealth+ with new customers, including Intermountain Health for Medicare Advantage.
Market Expansion: Ontrak is working towards executing a statement of work with a large Midwestern Medicaid plan for their 300,000 Medicaid members, representing a significant revenue opportunity.
New Partnerships: Partnerships with Intermountain Health and a Northeast regional plan for various populations provide powerful reference points for prospective customers.
Operational Efficiency: Ontrak's teams are now more than twice as productive as they were in 2021, achieving significant efficiencies and operational improvements.
Enrollment Growth: The company added 2,039 new members in Q1 2025, the highest since Q3 2021, indicating operational success.
Strategic Shift: Ontrak is evolving its business model to support health plans across multiple lines of business, optimizing opportunities with prospects.
NCQA Certification: Ontrak's recent certification as a Credentials Verification Organization serves as a key market differentiator, enhancing trust and operational excellence.
Revenue Decrease: Q1 revenue was $2 million, a 25% decrease compared to the same period last year, primarily due to the loss of a customer whose members disenrolled.
Enrollment Rate Decline: The enrollment rate decreased to 30% in Q1 2025 from 50% in Q4 2024, attributed to an increase in the outreach pool.
Gross Margin Reduction: Gross margin fell to 37% from 61% in Q4 2024, driven by lost customer revenue and a shift in member mix towards the lower-revenue Engage program.
Cash Flow Challenges: Q1 cash flow from operations was negative $2.7 million, although improved from previous periods, indicating ongoing financial strain.
Dependence on New Contracts: Future revenue growth is heavily reliant on converting bottom-of-funnel opportunities, which could potentially double current revenue.
Operational Efficiency Risks: While operational improvements have led to higher productivity, reliance on fewer employees may pose risks if member needs increase unexpectedly.
Regulatory Compliance: The company is working towards additional NCQA accreditation, which is crucial for maintaining trust and operational excellence in government programs.
Enrollment Growth: Total enrolled members reached 3,165, nearly doubling year-over-year, validating the effectiveness of the enhanced multi-solution approach.
Engage Program Success: The Engage program has expanded market reach, allowing Ontrak to serve members who may not require WholeHealth+ but still benefit from behavioral health support.
Provider Model Strategy: Significant progress in provider model strategy, offering flexibility to support health plans across multiple lines of business.
NCQA Certification: Achieved NCQA certification as a Credentials Verification Organization through April 2027, enhancing market differentiation.
Technology Investments: Investments in AI-driven engagement systems have improved operational productivity and care delivery.
Revenue Expectations: For Q2 2025, anticipated revenues are between $2.2 million and $2.6 million, representing an 8% to 22% sequential increase.
Annual Revenue Projection: Current customers under contract account for approximately $14 million to $16 million of annual revenue, with potential additional revenue of $15 million from bottom-of-funnel opportunities.
Gross Margin Outlook: Anticipate gross margin to maintain current levels and increase as the percentage of WholeHealth+ members rises.
Operational Cash Flow: Q1 cash flow from operations was negative $2.7 million, an improvement from previous periods.
Shareholder Return Plan: Ontrak has announced a financing agreement providing for up to $10 million of additional financing available to the Company as needed in the short term.
Despite enrollment growth and strategic initiatives, the company faces significant challenges: a 25% YoY revenue decrease, reduced gross margins, and ongoing cash flow issues. The positive aspects, such as NCQA certification and potential revenue growth, are overshadowed by reliance on new contracts and financial strain. The lack of significant Q&A insights further supports a negative outlook. Overall, the negatives outweigh the positives, suggesting a potential stock price decline of 2% to 8%.
Despite strong operational updates and strategic initiatives, the significant EPS miss and anticipated revenue decline raise concerns. While new partnerships and expansions are promising, the lack of immediate financial impact and unclear management responses add uncertainty. The absence of a share buyback program and potential regulatory and competitive risks further dampen sentiment. Given these factors, the stock price is likely to experience a negative movement.
The company faces significant challenges, including a notable revenue decline and cash flow issues. Despite some positive developments like new partnerships and customer acquisitions, the guidance indicates a substantial revenue drop in Q1 2025. Additionally, the lack of a share buyback program and high disenrollment rates further contribute to a negative outlook. The absence of analyst sentiment from the Q&A section does not offset these concerns.
Despite strategic initiatives and potential growth opportunities, the earnings call reveals significant challenges: a 31% revenue decrease YoY, declining gross margins, and liquidity concerns with reduced cash reserves. These outweigh the positive aspects like new customer acquisitions and revenue projections. The lack of a shareholder return plan further dampens sentiment. The Q&A section did not provide substantial positive insights to alter this outlook. Overall, the financial health and market strategy weaknesses suggest a negative stock price movement in the near term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.